Immucor, Inamed in human collagen deal
This article was originally published in Clinica
Norcross, Virginia-based Immucor is to develop human collagen mesh jointly with Inamed under an agreement signed between the companies on March 20. Immucor's subsidiary, Gamma Biologicals, which specialises in human cell line growth, will optimise the manufacturing process for the production of human raw collagen for Inamed. The collaboration will have two stages, with both companies hoping to enter a supply agreement after the development stage is completed. Immucor president Edward Gallup said his company had excess capacity at its production facility and "years of expertise" in growing human cell lines. Inamed made $74m in sales of dermal fillers in 2002.